首页> The Lancet. Oncology> Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.

Balixafortide plus eribulin in HER2-negative metastatic breast cancer: a phase 1, single-arm, dose-escalation trial.

导出原文传递

翻译打印收藏纠错

第一作者： Sonia,Pernas

第一单位： Institut Català d'Oncologia L'Hospitalet-Barcelona, Spain.

作者： Sonia,Pernas ^[1] ; Miguel,Martin ^[2] ; Peter A,Kaufman ^[3] ; Marta,Gil-Martin ^[1] ; Patricia,Gomez Pardo ^[4] ; Sara,Lopez-Tarruella ^[2] ; Luis,Manso ^[5] ; Eva,Ciruelos ^[5] ; Jose Alejandro,Perez-Fidalgo ^[6] ; Cristina,Hernando ^[6] ; Foluso O,Ademuyiwa ^[7] ; Katherine,Weilbaecher ^[7] ; Ingrid,Mayer ^[8] ; Timothy J,Pluard ^[9] ; Maria,Martinez Garcia ^[10] ; Linda,Vahdat ^[11] ; Jose,Perez-Garcia ^[12] ; Achim,Wach ^[13] ; Debra,Barker ^[13] ; Samson,Fung ^[14] ; Barbara,Romagnoli ^[13] ; Javier,Cortes ^[15]

作者单位： Institut Català d'Oncologia L'Hospitalet-Barcelona, Spain. ^[1] Instituto de Investigación Sanitaria Gregorio Marañón, Centro de Investigación Biomédica en Red Cáncer, Universidad Complutense, Madrid, Spain. ^[2] Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA. ^[3] Vall d'Hebron Institute of Oncology, Barcelona, Spain. ^[4] Hospital Universitario 12 de Octubre, Madrid, Spain. ^[5] Hospital Clínico Universitario de Valencia, INCLIVA, Centro de Investigación Biomédica en Red Cáncer, Valencia, Spain. ^[6] Department of Hematology and Oncology, Washington University, St Louis, MO, USA. ^[7] Vanderbilt University School of Medicine, Nashville, TN, USA. ^[8] St Luke's Cancer Institute, Kansas City, MO, USA. ^[9] Servei d'Oncologia Medica, Hospital del Mar, Barcelona, Spain. ^[10] Weill Cornell Medicine, New York, NY, USA. ^[11] Baselga Institute of Oncology, Hospital Quiron, Barcelona, Spain. ^[12] Polyphor, Allschwil, Switzerland. ^[13] Fung Consulting Healthcare and Life Sciences, Munich, Germany. ^[14] Breast Cancer Unit and Gynaecological Tumours, Ramon y Cajal University Hospital, Madrid, Spain; Vall d'Hebron Institute of Oncology, Barcelona, Spain; Baselga Oncology Institute, Quiron Group, Madrid and Barcelona, Spain. Electronic address: jacortes@vhio.net. ^[15]